Clinical Trials
207 trialsTTV ccRCC
Regina Elena Cancer Institute
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Fox Chase Cancer Center
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
ITHORinVHL
IRCCS San Raffaele
PEP-C
Centre Hospitalier Universitaire de Saint Etienne
RCCETT
Peking University Third Hospital
ZEBRA
Istituto Oncologico Veneto IRCCS
VolUS3D
Assistance Publique - Hôpitaux de Paris
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
University of Southern California
PP-RECURK
Gødstrup Hospital
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
KIDCaD
Charles University, Czech Republic
TARGET-RCC
IRCCS San Raffaele
RASROP-003
Humanitas Hospital, Italy
ELEPHAS-04
Mayo Clinic
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Mayo Clinic
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
ODYSSEY RCC
Duke University
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
COSTAR
Peking University First Hospital
Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning
First Affiliated Hospital of Fujian Medical University
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
Children's Hospital Medical Center, Cincinnati
PET/MR for Characterization of Renal Masses (RMs)
University of Texas Southwestern Medical Center
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
Mayo Clinic
RREIN
University Hospital, Lille
Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
Jinling Hospital, China
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Jinling Hospital, China
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
AURICRE
University of Yamanashi
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
International Multicentric Study ARON-1
Hospital of Macerata
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
Ohio State University Comprehensive Cancer Center
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Indiana University
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
First Affiliated Hospital of Fujian Medical University
Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study
First Affiliated Hospital of Fujian Medical University
ST-ICI02
University of Erlangen-Nürnberg Medical School
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
Peking University First Hospital
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
Duke University
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
University of Miami
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
First Affiliated Hospital of Fujian Medical University
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
Second Xiangya Hospital of Central South University
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy
Centre of Postgraduate Medical Education
iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
City of Hope Medical Center
PRO-RCC
PROspective Renal Cancer Cohort Foundation